AstraZeneca Pharma India Limited — Others, 19-08-2025: Copy of Newspaper Publication

AstraZeneca Pharma India has announced its financial results for the quarter ended 30 June 2025. Total income from operations rose to Rs 537.55 Cr, a significant increase from Rs 395.87 Cr in the same quarter last year. The company reported a net profit after tax of Rs 55.83 Cr, a notable improvement from a loss of Rs 11.79 Cr previously. Basic and diluted earnings per share stood at Rs 22.33. Operationally, the company ceased manufacturing at its site and began decommissioning plant and machinery, which are now fully depreciated. These results were reviewed by the Audit Committee and approved by the Board.